View in EDS HTML Full Text PDF Full Text

Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.

Saved in:
Bibliographic Details
Title: Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
Authors: Brum MCM; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil., Dos Santos Guimaraes I; Division of Clinical Research, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil., Ferreira LB; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil., Rangel LBA; Departament of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, Espírito Santo 29040‑090, Brazil., Maia RC; Stricto Sensu Graduate Program in Oncology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil., Nestal De Moraes G; Stricto Sensu Graduate Program in Oncology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil., Gimba ERP; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.
Source: Oncology reports [Oncol Rep] 2021 Feb; Vol. 45 (2), pp. 652-664. Date of Electronic Publication: 2020 Dec 01.
Publication Type: Journal Article
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33416171
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brum+MCM%22">Brum MCM</searchLink>; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.<br /><searchLink fieldCode="AU" term="%22Dos+Santos+Guimaraes+I%22">Dos Santos Guimaraes I</searchLink>; Division of Clinical Research, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.<br /><searchLink fieldCode="AU" term="%22Ferreira+LB%22">Ferreira LB</searchLink>; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.<br /><searchLink fieldCode="AU" term="%22Rangel+LBA%22">Rangel LBA</searchLink>; Departament of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, Espírito Santo 29040‑090, Brazil.<br /><searchLink fieldCode="AU" term="%22Maia+RC%22">Maia RC</searchLink>; Stricto Sensu Graduate Program in Oncology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.<br /><searchLink fieldCode="AU" term="%22Nestal+De+Moraes+G%22">Nestal De Moraes G</searchLink>; Stricto Sensu Graduate Program in Oncology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.<br /><searchLink fieldCode="AU" term="%22Gimba+ERP%22">Gimba ERP</searchLink>; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro 20231‑050, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229422756%22">Oncology reports</searchLink> [Oncol Rep] 2021 Feb; Vol. 45 (2), pp. 652-664. <i>Date of Electronic Publication: </i>2020 Dec 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22D%2EA%2E+Spandidos%22">D.A. Spandidos </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>9422756 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-2431 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221021335X%22">1021335X </searchLink><i>NLM ISO Abbreviation: </i>Oncol Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33416171
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3892/or.2020.7877
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 652
    Titles:
      – TitleFull: Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brum MCM
      – PersonEntity:
          Name:
            NameFull: Dos Santos Guimaraes I
      – PersonEntity:
          Name:
            NameFull: Ferreira LB
      – PersonEntity:
          Name:
            NameFull: Rangel LBA
      – PersonEntity:
          Name:
            NameFull: Maia RC
      – PersonEntity:
          Name:
            NameFull: Nestal De Moraes G
      – PersonEntity:
          Name:
            NameFull: Gimba ERP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2021 Feb
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1791-2431
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Oncology reports
              Type: main
ResultId 1